Overview
Double-blind, Randomised Study of A3384 in BAM/BAD
Status:
Completed
Completed
Trial end date:
2014-12-01
2014-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Albireo
Criteria
Inclusion Criteria:- Patient meets protocol specified criteria for Bile Acid Malabsorption/Bile Acid
Diarrhoea
- Patient has successfully completed study requirements with no clinically relevant
findings for physical exam, ECG, laboratory tests as applicable
Exclusion Criteria:
- Medical history or medical condition that would not make the patient a good candidate
for the study or limit the patient´s ability to complete the study
- Patient needs medications prohibited as specified in the protocol